Drug Group Lifts J&J; Shares Still Overvalued

We plan to raise our fair value for the pharma giant after second-quarter results, but valuation remains rich.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.